Hemoporfin-mediated photodynamic therapy (Hemoporfin-PDT) has been approved for port-wine stain (PWS) in China in 2017. This study evaluated the efficacy and safety of Hemoporfin-PDT for PWS in a real life setting and investigated factors that influence the efficacy. A multicenter retrospective study included patients with PWS who underwent Hemoporfin-PDT in 29 hospitals across China and completed at least two months of follow-up. The efficacy was evaluated based on patien photographs. A total of 1679 patients were included. After the first and second sessions of Hemoporfin-PDT, 63.5 and 75.3% of patients responded, respectively. The response rate of purple-type PWS was significantly lower than that of pink-type PWS (OR: 0.71, 95% CI: 0.54–0.94, P < 0.05), and there was no significant difference between thick- and pink-type (OR: 0.72, 95% CI: 0.42–1.22, P > 0.05). The response rate of PWS on the limbs was significantly lower than that on the mid-face (OR: 0.35, 95% CI: 0.23–0.53, P < 0.0001), while no significant difference was observed between PWS on the peripheral part of the face, neck or other parts of the body and PWS on the mid-face (P > 0.05). The response rate was lower in male patients with an age > 3 years or ≤ 6 years (P < 0.05). Previous treatment history did not affect the efficacy (P > 0.05). Hemoporfin-PDT was well tolerated. Patients with PWS have a good response and good tolerance to Hemoporfin-PDT.
Objective
To analyze γ-secretase gene mutations in a pedigree with acne inversa.
Methods
Clinical data were collected from a pedigree with acne inversa, which contained 30 members spanning 4 generations. Of these members, 12 were affected by acne inversa, and 9 of the affected members were alive. Peripheral blood DNA was obtained from the proband, his seven relatives (including 4 affected and 3 unaffected members), and 100 unrelated healthy human controls. PCR was performed to amplify all the coding exons and their flanking sequences of the NCSTN, PSEN1, PSENEN, Aph1 genes followed by DNA sequencing.
Results
A heterozygous insertion mutation (c.229_230insCACC)of the PSENEN gene, which led to translational frameshifting and resulted in dysfunciton of the PSENEN protein, was detected in all the 5 patients, but not in unaffected members or healthy controls.
Conclusion
There is a novel heterozygous insertion mutation c.229_230insCACC in the PSENEN gene, which may be the molecular basis of acne inversa in this family.
Key words:
Mutation; Genes, PSENEN; Acne inversa; gamma-Secretase
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Mao Q, Zhang W, Wang Q, et al. Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2017;34(2):177-179. doi:10.5114/ada.2017.67086. APA Mao, Q., Zhang, W., Wang, Q., Xiao, X., Chen, H., & Shao, X. et al. (2017). Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 34(2), 177-179. https://doi.org/10.5114/ada.2017.67086 Chicago Mao, Qiu-Xia, Wan-Lu Zhang, Qiang Wang, Xue-Min Xiao, Hao Chen, Xue-Bao Shao, and Hong Jia et al. 2017. "Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 34 (2): 177-179. doi:10.5114/ada.2017.67086. Harvard Mao, Q., Zhang, W., Wang, Q., Xiao, X., Chen, H., Shao, X., Jia, H., Feng, S., Wu, J., and Li, C. (2017). Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 34(2), pp.177-179. https://doi.org/10.5114/ada.2017.67086 MLA Mao, Qiu-Xia et al. "Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 34, no. 2, 2017, pp. 177-179. doi:10.5114/ada.2017.67086. Vancouver Mao Q, Zhang W, Wang Q, Xiao X, Chen H, Shao X et al. Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2017;34(2):177-179. doi:10.5114/ada.2017.67086.
Recent studies have shown that acne is not only a kind of dermatosis but also a main presentation of many systemic diseases and syndromes.In some cases,acne reflects the presence of systemic abnormalities,and can serve as an ideal model for investigations into the interactions among hormones,innate/ acquired immunity,inflammatory response and genetic factors.To learn the progress in molecular mechanisms,clinical manifestations and treatment of acne-associated syndromes will be beneficial to the understanding of acne pathogenesis and development of new therapies for acne.
Key words:
Acne, vulgaris; Syndrome; Research
To the Editor: Acne inversa (AI), also known as hidradenitis suppurativa, is a chronic recurrent inflammatory skin disease characterized by deep painful nodules and abscesses with resultant scarring mainly distributed in intertriginous areas. Loss-of-function mutations in γ-secretase (GS) genes are responsible for familial AI.[1] GS is a transmembrane protease composed of four essential protein subunits: one catalytic presenilin subunit (PSEN) and three cofactor subunits (nicastrin [NCSTN], presenilin enhancer 2 [PSENEN], anterior pharynx defective 1). GS is involved in cleavage of various type I membrane proteins, including amyloid precursor protein and Notch proteins. PSENEN directly binds to PSEN and is required for its autocatalytic cleavage and protease activity. To date, six mutations have been reported in PSENEN, all of which result in frameshift truncations and altered protein products, predominantly leading to haploinsufficiency.[2] Psoriasis is a genetically-determined proliferative and inflammatory entity, resulting from complex interactions between aberrant keratinocyte proliferation and differentiation, and a T-lymphocyte-mediated immune process. Dowling-Degos disease (DDD), a rare autosomal dominant disorder, is characterized by progressive reticulate hyperpigmentation and small dark-brown hyperkeratotic papules, mainly affecting flexural areas.[3] Herein, we report a proband and three other members of a three-generation Chinese Han AI family with co-occurrence of psoriasis and DDD, respectively. The 20-year-old male proband [III:5 in Figure 1A] presented with a 4-year relapsing history of multiple separated comedones, inflammatory papules, pustules, painful nodules, and cysts particularly located on the nape, upper back, and buttocks [Figure 1B and 1C]. At 1 year after the initial manifestations, he was afflicted by a concomitant itchy eruption characterized by scattered erythematous papules and macules with silvery-white lamellar scales mainly on the scalp and extremities, distinguishing itself from earlier lesions [Figure 1D]. Histopathological examination of an inflammatory nodule from the buttocks and a scaly papule from the forearm showed destruction of pilosebaceous follicles with surrounding marked fibrosis [Figure 1E] and regular acanthosis, confluent parakeratosis, and hypogranulosis with formation of a Munro microabscess [Figure 1F], respectively. Based on these findings, we diagnosed the patient with concomitant AI (Hurley stage I) and psoriasis. His 48-year-old mother (II:5) had similar, but more severe, inflammatory AI lesions with hypertrophic scars involving the nape, upper trunk, axillae, groins, and buttocks since puberty (Hurley stage II) [Figure 1 G–K]. Intriguingly, she also showed extensive comedones, pitted scars, and macular or reticulate hyperpigmentation located at flexural areas and the face, reminiscent of DDD [Figure 1 G–L]. The other six family members manifested either AI lesions (II:3, II:7, III:2, III:3) or AI-DDD lesions (I:2, II:1) with varying severity, revealing an autosomal dominant inheritance pattern [Figure 1A].Figure 1: Pedigree tree of the family (A). Clinical and histopathological findings in the proband of the pedigree (B–F): papules, pustules, nodules and cysts on the nape (B) and buttocks (C); erythematous papules and macules with slivery white lamellar scales on the extremities (D); histopathology of biopsies taken from the nape:destruction of pilosebaceous follicles with surrounding marked fibrosis (E, Hematoxylin-eosin staining, original magnification ×50); histopathology of biopsies taken from the forearm: regular acanthosis, confluent parakeratosis, hypogranulosis, and the formation of "Munro microabscess" (F, Hematoxylin-eosin staining, original magnification ×200). Clinical features of the proband's mother (G–L). Papules, pustules, nodules, cysts and hypertrophic scars on the nape (G), upper trunk (H), axillae (I), groins (J), and buttocks (K); besides, extensive comedones, pitted scars, and macular or reticulate hyperpigmentation are shown in flexural areas (I–K) and face (L). A heterozygous frameshift mutation c.66delG (p.F23LfsX46) was identified in the proband while was absent in unaffected II:6 (M). Comparison of the transcription levels of PSENEN-Notch signaling between the patients and healthy controls (n = 5) (N, ∗ P < 0.05 and † P < 0.01).The study was approved by the Institutional Ethical Review Boards of the Union Hospital of Fujian Medical University (No. 2019WSJK023). After receiving informed consent, we analyzed the entire coding regions and proximal flanking intronic sequences of the GS genes in the family by Sanger sequencing. In the proband and his mother, a heterozygous frameshift c.66delG mutation in exon 3 of the PSENEN gene was detected. This mutation segregated with affected, but not unaffected, family members, and was not observed in 100 control individuals [Figure 1M]. Remarkably, it was a recurrent mutation resulting in a premature termination codon (p.F23LfsX46).[2] Next, we extracted mRNA from peripheral lymphocytes of five AI patients in the family (I:2, II:1, II:3, II:5, III:5) and five normal non-consanguineous controls, and detected the relative PSENEN-Notch signaling molecule mRNA levels by real-time quantitative polymerase chain reaction. Compared with the controls, the patients exhibited remarkable reductions in PSENEN mRNA expression, indicating that the mutant was subjected to nonsense-mediated decay and resulted in loss-of-function. Meanwhile, Notch molecules including Notch1–3 and target gene HES1 were significantly suppressed in the patients, signifying that PSENEN haploinsufficiency contributed to deficiency in Notch signaling activity [Figure 1N]. The coexistence of AI and psoriasis in our case was probably not coincidental, because a recent study revealed that 28 of 440 AI patients manifested concomitant psoriasis vulgaris (6.4%).[4] Interestingly, similar to our case, hyperkeratosis and psoriasiform hyperplasia of the interfollicular epidermis with subepidermal inflammatory infiltrates are often observed in AI, resembling those evident in psoriasis. PSENEN is involved in intracellular cleavage of Notch proteins, which is necessary for activation of Notch signaling. Inherited or acquired impairment of Notch signaling is hypothesized to be the primary pathogenic event in AI. Within the epidermis, Notch signaling is involved in epidermal cell differentiation, hair follicular terminal differentiation, and epidermal proliferation.[1] Consistent with its role in hindering proliferation and promoting differentiation of keratinocytes, expression of Notch signaling is also decreased in psoriasis, characterized by hyperproliferation and disturbed differentiation of keratinocytes. Moreover, tumor necrosis factor-α and interleukin-12/23 inhibitors have demonstrated utility in AI, suggesting that the inflammation cascade is implicated in its pathogenesis, similar to psoriasis. Notch signaling is also a significant regulator of T-lymphocyte-mediated immune responses because it serves as a feedback repressor of over-activated natural immunity. Impaired Notch signaling may cause excessive proinflammatory macrophage cytokine expression (tumor necrosis factor-α, interleukin-1β, interleukin-23), thereby triggering Th17-mediated immune responses. Several cases of co-manifestation of AI-DDD with PSENEN mutations have been described, suggesting the possible existence of a common pathogenetic mechanism. Indeed, the two entities share important clinical and histopathological features including onset during puberty, flexural location, and follicular involvement. Only heterozygous mutations in PSENEN gave rise to pigmentation abnormalities including DDD, while the other two identified AI genes, PSEN1 and NCSTN, were not mentioned.[3] The Notch pathway has an integral role in skin homeostasis by mediating melanocyte proliferation and differentiation, and orchestrating interactions between melanocytes and keratinocytes.[3] It is intriguing that PSENEN knockdown in zebrafish led to development of aberrant pigmentation, resembling the DDD phenotype. Similar compromised PSENEN-Notch signaling was observed in keratinocytes from patients with AI-DDD and isolated AI in a recent study.[5] Taken together, the findings imply that PSENEN mutations in AI may predispose patients to occurrence and development of DDD through disrupted Notch signaling. The present report demonstrates three different phenotypes in one AI family: AI, AI-DDD, and AI-psoriasis. It is further suggested that diminished expression of PSENEN-Notch molecules may induce dysfunction of Notch signaling and be the unifying molecular mechanism underlying the significant phenotypic heterogeneity in this AI family. Acknowledgements The authors are most grateful to all members of the acne inversa family for taking part in their study. Funding This work was supported by grants from the National Natural Science Foundation of China (No. 81602785), the Natural Science Foundation of Fujian Province (No. 2017J05128), Fujian Provincial Health Technology Project (No. 2019-ZQN-47), and the Opening Foundation of Research Platform of Fujian University of Traditional Chinese Medicine (No. X2018018- Platform). Conflicts of interest None.
The Notch signaling pathway is an evolutionarily conserved signal transduction system. Notch receptors interact with ligands on adjacent cells to transduce cell signals and affect cell proliferation, differentiation and apoptosis. It has been reported in much literature that the Notch signaling pathway plays an important role in maintaining normal physiological functions of the skin, as well as in various skin diseases including inflammatory, autoimmune or pigmentary skin disorders, skin neoplasms, and so on. Although there is little experience in clinical application of Notch signaling inhibitors and activators, they are expected to provide new ideas for the treatment of skin diseases.
Key words:
Skin diseases; Receptors, Notch; Signaling pathway; Acne inversa; Autoimmune diseases; Skin neoplasms
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
